Neuroone Medical Technologies Stock Market Value
| NMTC Stock | USD 1.14 0.10 9.62% |
| Symbol | Neuroone |
Neuroone Medical Tec Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuroone Medical. If investors know Neuroone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuroone Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share | Quarterly Revenue Growth 0.311 | Return On Assets | Return On Equity |
The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuroone Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuroone Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuroone Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Neuroone Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neuroone Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neuroone Medical.
| 12/09/2024 |
| 01/08/2025 |
If you would invest 0.00 in Neuroone Medical on December 9, 2024 and sell it all today you would earn a total of 0.00 from holding Neuroone Medical Technologies or generate 0.0% return on investment in Neuroone Medical over 30 days. Neuroone Medical is related to or competes with BioSig Technologies,, Biomerica, Beyond Air, Movano, SANUWAVE Health, LENSAR, and Neuropace. NeuroOne Medical Technologies Corporation operates as a medical technology company More
Neuroone Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neuroone Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neuroone Medical Technologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.29 | |||
| Information Ratio | 0.0421 | |||
| Maximum Drawdown | 28.93 | |||
| Value At Risk | (9.52) | |||
| Potential Upside | 13.04 |
Neuroone Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neuroone Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neuroone Medical's standard deviation. In reality, there are many statistical measures that can use Neuroone Medical historical prices to predict the future Neuroone Medical's volatility.| Risk Adjusted Performance | 0.0464 | |||
| Jensen Alpha | 0.296 | |||
| Total Risk Alpha | 0.1399 | |||
| Sortino Ratio | 0.049 | |||
| Treynor Ratio | (0.27) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuroone Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neuroone Medical Tec Backtested Returns
Neuroone Medical appears to be extremely dangerous, given 3 months investment horizon. Neuroone Medical Tec has Sharpe Ratio of 0.0882, which conveys that the firm had a 0.0882% return per unit of risk over the last 3 months. By analyzing Neuroone Medical's technical indicators, you can evaluate if the expected return of 0.57% is justified by implied risk. Please exercise Neuroone Medical's Risk Adjusted Performance of 0.0464, downside deviation of 5.29, and Mean Deviation of 4.51 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Neuroone Medical holds a performance score of 6. The company secures a Beta (Market Risk) of -1.01, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Neuroone Medical are expected to decrease slowly. On the other hand, during market turmoil, Neuroone Medical is expected to outperform it slightly. Please check Neuroone Medical's rate of daily change, period momentum indicator, as well as the relationship between the skewness and potential upside , to make a quick decision on whether Neuroone Medical's current price movements will revert.
Auto-correlation | 0.04 |
Virtually no predictability
Neuroone Medical Technologies has virtually no predictability. Overlapping area represents the amount of predictability between Neuroone Medical time series from 9th of December 2024 to 24th of December 2024 and 24th of December 2024 to 8th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neuroone Medical Tec price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current Neuroone Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.04 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Neuroone Medical Tec lagged returns against current returns
Autocorrelation, which is Neuroone Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Neuroone Medical's stock expected returns. We can calculate the autocorrelation of Neuroone Medical returns to help us make a trade decision. For example, suppose you find that Neuroone Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Neuroone Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Neuroone Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Neuroone Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Neuroone Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Neuroone Medical Lagged Returns
When evaluating Neuroone Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Neuroone Medical stock have on its future price. Neuroone Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Neuroone Medical autocorrelation shows the relationship between Neuroone Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Neuroone Medical Technologies.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Neuroone Medical Correlation, Neuroone Medical Volatility and Neuroone Medical Alpha and Beta module to complement your research on Neuroone Medical. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Neuroone Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.